Evidence map›Paper›PMID 24776636›Full record

ArticleHealth promotion practice2015

Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Amy Jewett, Arika Garg, Katherine Meyer, Laura Danielle Wagner, Katherine Krauskopf, Kimberly A Brown, Jen-Jung Pan, Omar Massoud, Bryce D Smith, David B Rein

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Health promotion practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02123212 (Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02123212 nacompletednot on this map

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

TypeinterventionalSponsorNational Opinion Research CenterRan2013 to 2014Enrolled29,607ConditionsHepatitis C, Chronic Hepatitis CArmsMailer, In-person recruitment, EHR Alert
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 1 country.

Amy JewettOak Ridge Institute for Science and Education, Clinton, TN, USA.
Arika GargNORC at University of Chicago, Chicago, IL, USA.
Katherine MeyerNORC at University of Chicago, Chicago, IL, USA.
Laura Danielle WagnerRTI International, Waltham, MA, USA.
Katherine KrauskopfIcahn School of Medicine at Mount Sinai, New York City, NY, USA.
Kimberly A BrownHenry Ford Hospital, Detroit, MI, USA.
Jen-Jung PanUniversity of Texas Health Science Center at Houston, Houston, TX, USA.
Omar MassoudUniversity of Alabama at Birmingham, Birmingham, AL, USA.
Bryce D SmithCenters for Disease Control and Prevention, Atlanta, GA, USA bsmith6@cdc.gov.
David B ReinNORC at University of Chicago, Chicago, IL, USA.
University of Chicago · USCenters for Disease Control and Prevention · USHenry Ford Hospital · USIcahn School of Medicine at Mount Sinai · USNational Opinion Research Center · USOak Ridge Associated Universities · USRTI International · USThe University of Texas Health Science Center at Houston · USUniversity of Alabama at Birmingham · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundIn 1998, the Centers for Disease Control and Prevention (CDC) published Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease, recommending HCV testing for populations most likely to be infected with HCV. However, the implementation of risk-based screening has not been widely adopted in health care settings, and 45% to 85% of infected U.S. adults remain unidentified.

objectivesTo develop a better understanding of why CDC's 1998 recommendations have had limited success in identifying persons with HCV infection and provide information about how CDC's 2012 Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among Persons Born During 1945-1965 may be implemented more effectively.

designQualitative data were collected and analyzed from a multidisciplinary team as part of the Birth Cohort Evaluation to Advance Screening and Testing for Hepatitis C project. RESPONDENTS: Nineteen providers were asked open-ended questions to identify current perspectives, practices, facilitators, and barriers to HCV screening and testing. Providers were affiliated with Henry Ford Hospital, Mount Sinai Hospital, the University of Alabama, and the University of Texas Health Science Center.

resultsRespondents reported the complexity of the 1998 recommendations, and numerous indicated risk factors were major barriers to effective implementation. Other hindrances to hepatitis C testing included physician discomfort in asking questions about socially undesirable behaviors and physician uncertainty about patient insurance coverage.

conclusionImplementation of the CDC's 2012 recommendations could be more successful than the 1998 recommendations due to their relative simplicity; however, effective strategies need to be used for dissemination and implementation for full success.

Indexed as

Centers for Disease Control and Prevention, U.S.Guideline AdherenceHepatitis CHepatitis C, ChronicHumansMass ScreeningPractice Guidelines as TopicPrimary Health CareRisk FactorsUnited Statesdelivery of health careguidelineshepatitisscreening

Identifiers

PMID24776636
PMCPMC5747241
OpenAlexW2113961490

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.